Compared with the highest quartile, individuals in the lowest quartile of handgrip strength had a 46% higher risk of developing cardiometabolic multimorbidity (HR 1.46).
Cohort (n=493,774)
Yes
Does lower handgrip strength predict the development of cardiometabolic multimorbidity and all-cause mortality in adults?
Lower handgrip strength is an independent predictor of developing cardiometabolic multimorbidity and is associated with higher all-cause mortality in patients who already have cardiometabolic multimorbidity.
Hazard Ratio: 1.46 (95% CI 1.34–1.6)
p-value: p=<0.0001
BACKGROUND: Cardiometabolic multimorbidity (CM) is an increasing public health and clinical concern. However, predictors for the development and prognosis of CM are poorly understood. The aims of this study were to investigate the relation between handgrip strength (HGS) and the risk of CM and to examine the association of HGS with all-cause mortality risk among patients with CM. METHODS: This prospective cohort study involved 493,774 participants from the UK Biobank. CM was defined as the simultaneous occurrence of two or more of the following conditions: type 2 diabetes, stroke, and coronary heart disease (CHD). Cox proportional hazards models were performed to estimate hazard ratios (HRs) and 95% confidence intervals (95% CIs). RESULTS: During a median follow-up of 12.1 years, 4701 incident CM cases were documented among participants with none cardiometabolic disease at baseline. Compared with the fourth quartile (Q4), the multivariable adjusted HR (95% CI) value of Q1 of HGS for developing CM was 1.46 (1.34-1.60). In participants with one cardiometabolic disease at baseline, participants in Q1 of HGS also possessed higher risk of CM than those in Q4, with HRs (95% CIs) being 1.35 (1.23-1.49) in patients with type 2 diabetes, 1.23 (1.04-1.46) in patients with stroke, and 1.23 (1.11-1.36) in patients with CHD. For participants with CM at recruitment, HGS was also associated with the risk of all-cause mortality (Q1 vs. Q4 HR: 1.57, 95% CI: 1.36-1.80). CONCLUSIONS: Our study provided novel evidence that HGS could be an independent predictor of morbidity and all-cause mortality of CM.
Lu et al. (Fri,) conducted a cohort in Cardiometabolic multimorbidity (n=493,774). Handgrip strength vs. Highest quartile (Q4) of handgrip strength was evaluated on Incident cardiometabolic multimorbidity (CM) (HR 1.46, 95% CI 1.34-1.60, p=<0.0001). Compared with the highest quartile, individuals in the lowest quartile of handgrip strength had a 46% higher risk of developing cardiometabolic multimorbidity (HR 1.46).